ALL ORAL COMBINATION OF VINORELBINE AND CAPECITABILE AS A FIRST LINE TREATMENT IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Shehata, Samir [1 ]
Khalaf, Marwa [1 ]
机构：
[1] Assiut Univ, Dept Med Oncol, Assiut, Egypt
来源：
BREAST | 2017年 / 36卷
关键词：
D O I：
10.1016/S0960-9776(17)30706-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO87
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [1] All oral combination of vinorelbine and capecitabine as a first line treatment in patients (pts) with metastatic breast cancer (MBC)
    Shehata, S.
    Khalaf, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Phase I study of an all-oral combination of vinorelbine (VRL) and cyclophosphamide (Ctx) as second line treatment in patients with metastatic breast cancer (MBC)
    ten Tije, AJ
    Lieverst, J
    Seynaeve, C
    Schornagel, JH
    Brandely, M
    Blanchot, G
    ter Steeg, JD
    Verweij, J
    Schellens, JHM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S42 - S42
  • [3] Oral Vinorelbine in Combination With Capecitabine as a First Line Treatment in Patients (pts) With Metastatic Breast Cancer (MBC) Previously Treated With Anthracyclines ± Taxanes - Preliminary Results of a Multicentric Phase II Trial in Egypt
    Kandil, A.
    Hamada, E.
    Moawad, M.
    El Arab, L. Ezz
    Metwalli, H.
    Bathiouny, M.
    Mourad, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S351 - S351
  • [4] Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer
    Ardizzoia, Antonio
    Colombo, Ilaria
    Giordano, Monica
    Aglione, Stefania
    Isa, Luciano
    Scanni, Alberto
    Scognamiglio, Giovanni
    Bertolini, Alessandro
    Villa, Federica
    Gardani, Gianstefano
    TUMORI JOURNAL, 2007, 93 (06): : 544 - 549
  • [5] Cardiac safety of the lapatinib/letrozole combination as first-line therapy in patients (pts) with metastatic breast cancer (MBC)
    Zembryki, D.
    Gomez, H.
    Koehler, M.
    Koehler, M.
    Johnston, S.
    Pippen, J.
    Florance, A.
    O'Rourke, L.
    Maltzman, J.
    Pivot, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Liang Huang
    Xiaojia Wang
    Liheng Zhou
    Lijun Di
    Hongyu Zheng
    Zefei Jiang
    Yongsheng Wang
    Xiangqun Song
    Jifeng Feng
    Shiying Yu
    Yunpeng Liu
    Hong Zheng
    Kunwei Shen
    Zhongsheng Tong
    Zhimin Shao
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 205 - 215
  • [7] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Huang, Liang
    Wang, Xiaojia
    Zhou, Liheng
    Di, Lijun
    Zheng, Hongyu
    Jiang, Zefei
    Wang, Yongsheng
    Song, Xiangqun
    Feng, Jifeng
    Yu, Shiying
    Liu, Yunpeng
    Zheng, Hong
    Shen, Kunwei
    Tong, Zhongsheng
    Shao, Zhimin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 205 - 215
  • [8] A pooled analysis of efficacy and safety of vinorelbine in combination with capecitabine in first-line metastatic breast cancer (MBC)
    Valev, Spartak S.
    Taushanova, Margarita
    Krasteva, Ely
    ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [9] Efficacy and safety of oral vinorelbine (NVBO) in first- or second-line metastatic breast cancer (MBC)
    Blancas, I.
    Morales, S.
    Diaz, N.
    Barnadas, A.
    Gonzalvez, M. L.
    del Barco, S.
    Lopez de Ceballos, M. H.
    Perez, F. J.
    Llombart-Cussac, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Treatment of metastatic breast cancer (MBC) with Vinorelbine and Docetaxel
    Savio, Giuseppina
    Leonardi, Vita
    Alu, Massimiliano
    Laudani, Agata
    Calabria, Caterina
    Scianna, Caterina
    Agostara, Biagio
    Ascoli, Maurizio
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
12345